Zuojun Li

Zuojun Li

Auto-generated profile, based on publicly available information

Zuojun Li

Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2010 in Journal of Fluorescence
Verified
Journal Article
Closed access
PDF file
QZQing-Ping Zuo
Qing-Ping Zuo
BLBing Li
Bing Li
QPQi Pei
Qi Pei
ZLZuojun Li
Zuojun Li
SLShi-Kun Liu
Shi-Kun Liu

12 July 2022 in Medicina Clinica
Verified
Journal Article
Closed access
CWCuifang Wu
Cuifang Wu
ZLZuojun Li
Zuojun Li
CWChunjiang Wang
Chunjiang Wang
ZDZhenzhen Deng
Zhenzhen Deng

5 April 2021 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
ZLZuojun Li
Zuojun Li
YSYanhong Su
Yanhong Su
DYDan Yi
Dan Yi
CWCuifang Wu
Cuifang Wu
WFWeijin Fang
Weijin Fang
CWChunjiang Wang
Chunjiang Wang


12 January 2022 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
CWChunjiang Wang
Chunjiang Wang
ZFZhiqiang Fan
Zhiqiang Fan
YHYang He
Yang He
WFWeijin Fang
Weijin Fang
WSWei Sun
Wei Sun
ZLZuojun Li
Zuojun Li

31 July 2022 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
HLHaibo Lei
Haibo Lei
HDHongyi Deng
Hongyi Deng
XLXiang Liu
Xiang Liu
ZLZuojun Li
Zuojun Li
CWChunjiang Wang
Chunjiang Wang
Acute generalized exanthematous pustulosis (AGEP) is a serious and rare adverse reaction of cephalosporins. We aimed to describe the clinical features of cephalosporin-induced AGEP and provide a reference for rational clinical use of cephalosporins. We systematically searched Chinese and English databases for cephalosporin-induced TGEP-related case reports, retrospective studies, clinical studies, and review articles published before May 2022. A total of 43 patients from 35 articles were eligible, of which 28 (65.1%) were female, with a median age of 69 years. A total of 11 cephalosporins were suspected, the most commonly involved were ceftriaxone (41.9%), cephalexin (16.3%), and cefepime (9.3%). AEGP erupted primarily within 14 days after administration, manifested as nonfollicular pustules on an erythematous base, distributed favourably to the extremities (44.2%), trunk (23.3%), face (23.3%), and could involve the oral mucosa (11.6%). During AGEP resolution, the affected area had desquamation (39.5%). The acute phase of the disease may be accompanied by fever (>38.0°C) and elevated neutrophil count (>7500/mm3 ). Histology of AGEP showed subcorneal pustules (56.3%), intraepidermal cavernous pustules (37.5%), with papillary dermal edema (37.5%), containing neutrophils and eosinophilic infiltration (71.9%). After drug discontinuation, the median time to resolution of AGEP symptoms was 10 days (range 2, 90). Cephalosporin-induced AGEP is rare and should be properly diagnosed. This serious cutaneous adverse reaction is self-limiting and has a favourable prognosis, usually resolves with drug interruption, and may require additional interventions, such as topical steroids.